Products and Services
|
||
![]() |
||||||||||||||||||||||||||||
*Not all titles are enabled for PPV access. Login To Trials & Price Quotes Show Request Queue |
Download a PDF version of this page
Mels Sluyse, the editor of the journals APOPTOSIS and ANTI-CANCER DRUGS, has brought together a collection of papers written by the world’s leading experts in these fields. Novel drugs are being developed which interact with the programmed cell death (apoptotic) machinery in cancer cells, thereby causing these cells to commit suicide and to be removed from the body. Research is also directed to investigate why the cancer cells sometimes lose the ability to undergo apoptosis after a certain period of time and methods are being developed to reactivate this cell death process. This book is intended for workers in the field and clinicians as a useful guide of the state of affairs in this exciting field which may offer more effective possibilities for treatment of cancer patients. Broad Subjects: Clinical Medicine; Pharmacology; Life Sciences Specific Subjects: Oncology; Biochemistry & Biophysics; Cell Biology; Pharmaceuticals |
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Products
& Services - Online
Community - Events - Training & Documentation - Technical Support - About Ovid - Contacts
& Locations - Terms
of Use (last updated (05/28/09) - Privacy
Policy ©2009 Ovid Technologies, Inc. All Rights Reserved. Ovid® is a registered trademark of Ovid Technologies, Inc. and cannot be reproduced without permission. |